Showing results (61-70 of 167) with videos related to
Sort By:
Pageof 17
BJU International|November 5, 2025
Target trial emulation of early docetaxel and enzalutamide for metastatic hormone-sensitive prostate cancerYu Yang Soon, Ian C Marschner, I Manjula Schou, et al.Lung Cancer (Amsterdam, Netherlands)|September 7, 2010
Lung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: what makes it worthwhile?Prunella Blinman, Sue-Anne McLachlan, Anna K Nowak, et al.JAMA Network Open|September 17, 2024
Lu-177 PSMA vs Comparator Treatments and Survival in Metastatic Castration-Resistant Prostate CancerYu Yang Soon, Ian C Marschner, Manjula Schou, et al.BJU International|December 21, 2012
Intravesical chemotherapy plus bacille Calmette-Guérin in non-muscle invasive bladder cancer: a systematic review with meta-analysisBaerin B Houghton, Venu Chalasani, Dickon Hayne, et al.Annals of Surgical Oncology|November 17, 2016
Sentinel-Lymph-Node-Based Management or Routine Axillary Clearance? Five-Year Outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 Trial: Assessment and Incidence of True LymphedemaNeil Wetzig, Peter Grantley Gill, David Espinoza, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 16, 2025
Development and validation of a prognostic model incorporating patient reported outcomes for advanced gastric and esophageal carcinoma (AGOC) using individual patient data from two AGITG randomized clinical trialsSayeda Kamrun Naher, David Espinoza, Peter Grimison, et al.Internal Medicine Journal|January 11, 2024
Patients' perception of the benefits of palliative systemic therapy for advanced cancerShalini Subramaniam, Diana H Adams, Annette Tognela, et al.Clinical Trials (London, England)|June 3, 2015
Development and piloting of a decision aid for women considering participation in the Sentinel Node Biopsy versus Axillary Clearance 2 breast cancer trialIlona Juraskova, Phyllis Butow, Alana Fisher, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 14, 2022
Using three scenarios to explain life expectancy in advanced cancer: attitudes of patients, family members, and other healthcare professionalsSharon H Nahm, Martin R Stockler, Andrew J Martin, et al.Journal of Cancer Research and Clinical Oncology|October 31, 2022
Value of central review of RECIST v1.1 outcomes in the AGITG INTEGRATE randomised phase 2 international trial for advanced oesophago-gastric cancerKatrin M Sjoquist, Andrew Martin, Nick Pavlakis, et al.Pageof 17